Related references
Note: Only part of the references are listed.miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation
Yushuai Mi et al.
CANCER LETTERS (2017)
Cytoplasmic Drosha Is Aberrant in Precancerous Lesions of Gastric Carcinoma and Its Loss Predicts Worse Outcome for Gastric Cancer Patients
Hailong Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer
Yeting Hong et al.
SCIENTIFIC REPORTS (2016)
Nuclear termination of STAT3 signaling through SIPAR (STAT3-Interacting Protein As a Repressor)-dependent recruitment of T cell tyrosine phosphatase TC-PTP
Fangli Ren et al.
FEBS LETTERS (2015)
MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis
Jian-Guo Wu et al.
GASTRIC CANCER (2015)
MicroRNA-181a Inhibits Tumor Proliferation, Invasiveness, and Metastasis and Is Downregulated in Gastric Cancer
Feng Lin et al.
ONCOLOGY RESEARCH (2014)
Cinobufacin Suppresses Cell Proliferation via miR-494 in BGC-823 Gastric Cancer Cells
Rong-Ping Zhou et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Widespread context dependency of microRNA-mediated regulation
Florian Erhard et al.
GENOME RESEARCH (2014)
GdX/UBL4A Specifically Stabilizes the TC45/STAT3 Association and Promotes Dephosphorylation of STAT3 to Repress Tumorigenesis
Yangmeng Wang et al.
MOLECULAR CELL (2014)
MicroRNA-181a Functions as an Oncomir in Gastric Cancer by Targeting the Tumour Suppressor Gene ATM
Xiangyang Zhang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Factors Associated with Mammography Adherence among Married Chinese Women in Yanbian, China
Moonhee Gang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Oncogenic ERBB3 Mutations in Human Cancers
Bijay S. Jaiswal et al.
CANCER CELL (2013)
MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling
William W. Du et al.
JOURNAL OF CELL SCIENCE (2013)
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
Hazel Tye et al.
CANCER CELL (2012)
MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6
Xiangyang Zhang et al.
TUMOR BIOLOGY (2012)
Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer
Fuqin Su et al.
BREAST CANCER RESEARCH (2012)
miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras
Ki-Hyuk Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang et al.
NATURE GENETICS (2011)
Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM
Y. Wang et al.
ONCOGENE (2011)
Inside the human cancer tyrosine phosphatome
Sofi G. Julien et al.
NATURE REVIEWS CANCER (2011)
Prox1 expression is negatively regulated by miR-181 in endothelial cells
Jan Kazenwadel et al.
BLOOD (2010)
Protein-tyrosine Phosphatase PTPN9 Negatively Regulates ErbB2 and Epidermal Growth Factor Receptor Signaling in Breast Cancer Cells
Taichang Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Prognostic Significance of Expression of a Single MicroRNA, miR-181a, in Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Sebastian Schwind et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
Tetsuya Ueda et al.
LANCET ONCOLOGY (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
MicroRNA dysregulation in gastric cancer: a new player enters the game
W. K. K. Wu et al.
ONCOGENE (2010)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Identification of MicroRNA-181 by Genome-Wide Screening as a Critical Player in EpCAM-Positive Hepatic Cancer Stem Cells
Junfang Ji et al.
HEPATOLOGY (2009)
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
C. Gravalos et al.
ANNALS OF ONCOLOGY (2008)
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
Lei Shi et al.
BRAIN RESEARCH (2008)
MicroRNA expression in cytogenetically normal acute myeloid leukemia
Guido Marcucci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miR-181a is an intrinsic modulator of T cell sensitivity and selection
Qi-Jing Li et al.
CELL (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Identification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling
Charles Y. Cho et al.
CELL METABOLISM (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function
YC Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
MicroRNA biogenesis: Coordinated cropping and dicing
VN Kim
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Control of vesicle fusion by a tyrosine phosphatase
H Huynh et al.
NATURE CELL BIOLOGY (2004)
Prediction of mammalian microRNA targets
BP Lewis et al.
CELL (2003)
PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells
MJ Xu et al.
BLOOD (2003)
Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148
MG Lampugnani et al.
JOURNAL OF CELL BIOLOGY (2003)
Purification and characterization of protein tyrosine phosphatase PTP-MEG2
Y Qi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Share Paper
